User profiles for L. Holden
Lisa a HoldenPenn state Verified email at psu.edu Cited by 2184 |
The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guideline
…, RKS Wong, L Holden, L Robb-Blenderman… - Supportive Care in …, 2006 - Springer
Goals of work To develop a practice guideline report on the questions: What are the optimal
methods to prevent acute skin reactions (occurring within the first 6 months of irradiation) …
methods to prevent acute skin reactions (occurring within the first 6 months of irradiation) …
Cancer among farmers: a meta-analysis
…, B Ireland, J Kaneene, S Schuman, L Holden - Annals of …, 1998 - Elsevier
PURPOSE: We conducted a meta-analysis of 37 studies to assess whether farmers had
elevated rates for several cancers, as was concluded in a previous meta-analysis of 21 studies. …
elevated rates for several cancers, as was concluded in a previous meta-analysis of 21 studies. …
Factors affecting open-set word recognition in adults with cochlear implants
LK Holden, CC Finley, JB Firszt, TA Holden… - Ear and …, 2013 - journals.lww.com
… of E A (blue line), the length along the electrode trajectory (L EL ) from E B to E A (green line),
… E B (L BE ). The electrode insertion length to E A is then the sum of lengths L BE and L EL . …
… E B (L BE ). The electrode insertion length to E A is then the sum of lengths L BE and L EL . …
A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites
DM Patterson, N Murugaesu, L Holden… - International Journal of …, 2008 - ijgc.bmj.com
… IU/L) in 7 of 28 patients (3 dysgerminoma and 4 teratoma), and … /L, mean 16,723 IU/L) than
those in the three patients who did subsequently relapse (range 7–3772 IU/L, mean 1296 IU/L…
those in the three patients who did subsequently relapse (range 7–3772 IU/L, mean 1296 IU/L…
Comparison of methods of in vitro dry matter digestibility for ten feeds
LA Holden - Journal of dairy science, 1999 - Elsevier
… g of CaCl2·H2O, and 0.5 g of urea in 1 L of deionized water) and solution B (15 g of Na2CO3
… to 39C and adding 20 ml of solution B to 1 L of solution A. The pH of the buffer solution was …
… to 39C and adding 20 ml of solution B to 1 L of solution A. The pH of the buffer solution was …
Role of electrode placement as a contributor to variability in cochlear implant outcomes
CC Finley, TA Holden, LK Holden… - Otology & …, 2008 - journals.lww.com
Suboptimal cochlear implant (CI) electrode array placement may reduce presentation of
coded information to the central nervous system and, consequently, limit speech recognition. …
coded information to the central nervous system and, consequently, limit speech recognition. …
The composition of glyphosate-tolerant soybean seeds is equivalent to that of conventional soybeans
…, DL Nida, MR Bailey, J MacDonald, LR Holden… - The Journal of …, 1996 - Elsevier
One important aspect of the safety assessment of genetically engineered crops destined for
food and feed uses is the characterization of the consumed portion of the crop. One crop …
food and feed uses is the characterization of the consumed portion of the crop. One crop …
Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine
Chemokines and their receptors control cell migration during development, immune system
responses, and in numerous diseases, including inflammation and cancer. The structural …
responses, and in numerous diseases, including inflammation and cancer. The structural …
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
M Bower, ES Newlands, L Holden, D Short… - Journal of Clinical …, 1997 - ascopubs.org
PURPOSE To evaluate the results of etoposide, methotrexate, and dactinomycin alternating
with cyclophosphamide and vincristine (EMA/CO) chemotherapy in women with high-risk …
with cyclophosphamide and vincristine (EMA/CO) chemotherapy in women with high-risk …
Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000
IA McNeish, S Strickland, L Holden… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: We have simplified the treatment of gestational trophoblastic disease (GTD) in
order to reduce the number of patients exposed to potentially carcinogenic chemotherapy. …
order to reduce the number of patients exposed to potentially carcinogenic chemotherapy. …